pISSN 1226-6051
eISSN 2508-786X

Table. 2.

Table. 2.

Demographic information

Characteristics All non-CDP CDP P value

n=74,165 n=73,739 n=426

Number (%) Number (%) Number (%)
Sex 0.190
Male 39,615 (53.4) 39,374 (53.4) 241 (56.6)
Female 34,550 (46.6) 34,365 (46.6) 185 (43.4)

Age (years) <0.01
20-39 2,754 (3.7) 2,741 (3.7) 13 (3.1)
40-49 9,993 (13.5) 9,937 (13.5) 56 (13.1)
50-59 20,687 (27.9) 20,595 (27.9) 92 (21.6)
60-69 20,231 (27.3) 20143 (27.3) 88 (20.7)
70-74 14,142 (19.1) 14032 (19.0) 110 (25.8)
≥75 6,358 (8.6) 6291 (8.5) 67 (15.7)

Comorbidity
Dyslipidemia 34,562 (46.6) 34,332 (46.6) 230 (54.0) <0.01
Coronary artery diseasea 2,836 (3.8) 2,784 (3.8) 52 (12.2) <0.01
Chronic heart failure 2,127 (2.9) 2,079 (2.8) 48 (11.3) <0.01
Stroke 1,089 (1.5) 1,073 (1.5) 16 (3.8) <0.01
Chronic kidney disease 232 (0.3) 222 (0.3) 10 (2.3) <0.01

Insurance <0.01
NHI 70,570 (95.2) 70,182 (95.2) 388 (91.1)
MedAid+PVI 3,595 (4.8) 3,557 (4.8) 38 (8.9)

Institution <0.01
Tertiary hospital 2,002 (2.7) 1,973 (2.7) 29 (6.8)
General hospital 5,755 (7.8) 5,699 (7.7) 56 (13.1)
Clinic 57,928 (78.1) 57,647 (78.2) 281 (66.0)
Public health 2,637 (3.6) 2,620 (3.6) 17 (4.0)
Others 5,843 (7.9) 5,800 (7.9) 43 (10.1)

Specialty 0.195
Internal medicine 61,299 (82.7) 60,961 (82.7) 338 (79.3)
Family medicine 3,670 (4.9) 3,645 (4.9) 25 (5.9)
Others 9,196 (12.4) 9,133 (12.4) 63 (14.8)

Area <0.01
Seoul 14,577 (19.7) 14,489 (19.6) 88 (20.7)
Kyeonggib 21,627 (29.2) 21,533 (29.2) 94 (22.1)
Gyeongsangc 18,216 (24.6) 18,096 (24.5) 120 (28.2)
Jeollae 7,963 (10.7) 7,907 (10.7) 56 (13.1)
Chungcheongf 8,147 (11.0) 8,103 (11.0) 44 (10.3)
Gangwon 2,688 (3.6) 2,666 (3.6) 22 (5.2)
Jeju 947 (1.3) 945 (1.3) 2 (0.5)

CDP, Class Duplicate Prescriptions; NHI, National Health Insurance; MedAid, Medical Aid; PVI, Patriots and Veterans Insurance

a Coronary artery disease; angina and myocardial infarction

b Kyeonggi-do and Incheon Metropolitan City are included

c Kyeongsangnam-do, Kyeongsangbuk-do, Busan Metropolitan City, Ulsan Metropolitan City and Daegu Metropolitan City are included.

d Jeollanam-do, Jeollabuk-do and Gwangju Metropolitan City are included

e Chungcheongnam-do, Chungcheongbuk-do, Daejeon Metropolitan City and Sejong City are included

Korean J Clin Pharm 2022;32:125-32 https://doi.org/10.24304/kjcp.2022.32.2.125
© 2022 Korean J Clin Pharm